drugset / Trial / NCT00540670
A Double-Blind Study of E5555 in Japanese Subjects With Coronary Artery Disease
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this study is to assess the safety and tolerability of E5555 in Japanese subjects with coronary artery disease.
Timeline
- Start
- 2007-10
- Primary completion
- 2009-03
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Atopaxar | Small molecule | 50 mg | Oral |
| Subject | Atopaxar | Small molecule | 100 mg | Oral |
| Subject | Atopaxar | Small molecule | 200 mg | Oral |